Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease

[1]  J. H. Rudd,et al.  The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial , 2018, PloS one.

[2]  Z. Fayad,et al.  Imaging Atherosclerosis , 2016, Circulation research.

[3]  M. Polkey,et al.  Effective Bronchoscopic Lung Volume Reduction Accelerates Exercise Oxygen Uptake Kinetics in Emphysema. , 2016, Chest.

[4]  M. Woodward,et al.  Does Vascular Calcification Accelerate Inflammation?: A Substudy of the dal-PLAQUE Trial. , 2016, Journal of the American College of Cardiology.

[5]  L. Wain,et al.  Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank , 2015, The Lancet. Respiratory medicine.

[6]  M. Sadatsafavi,et al.  Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. , 2015, The Lancet. Respiratory medicine.

[7]  J. Rudd,et al.  PET imaging of inflammation in atherosclerosis , 2014, Nature Reviews Cardiology.

[8]  J. Pépin,et al.  Arterial stiffness in COPD. , 2014, Chest.

[9]  P. Barnes.  Cellular and molecular mechanisms of chronic obstructive pulmonary disease. , 2014, Clinics in chest medicine.

[10]  E. Benjamin,et al.  Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. , 2014, Journal of the American College of Cardiology.

[11]  T. Brady,et al.  Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. , 2013, JACC. Cardiovascular imaging.

[12]  M. Polkey,et al.  Evaluation of losmapimod in patients with chronic obstructive pulmonary disease (COPD) with systemic inflammation stratified using fibrinogen ('EVOLUTION'): RATIONALE and protocol , 2013 .

[13]  Z. Fayad,et al.  Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. , 2013, Journal of the American College of Cardiology.

[14]  T. Brady,et al.  Focal Arterial Inflammation Precedes Subsequent Calcification in the Same Location: A Longitudinal FDG-PET/CT Study , 2013, Circulation. Cardiovascular imaging.

[15]  M. Reiser,et al.  Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study , 2013, The International Journal of Cardiovascular Imaging.

[16]  A. Kastrati,et al.  Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease. , 2013, The American journal of cardiology.

[17]  Aad van der Lugt,et al.  Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study. , 2013, American journal of respiratory and critical care medicine.

[18]  W. MacNee,et al.  Cardiovascular disease in COPD: mechanisms. , 2013, Chest.

[19]  B. Celli,et al.  Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[20]  J. H. Rudd,et al.  Anti-Tumor Necrosis Factor-&agr; Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis , 2012, Circulation.

[21]  L. Edwards,et al.  Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[22]  E. V. van Beek,et al.  Systemic elastin degradation in chronic obstructive pulmonary disease , 2012, Thorax.

[23]  J. Cockcroft,et al.  Aortic calcification, arterial stiffness and bone mineral density in patients with COPD☆ , 2011 .

[24]  Sungeun Kim,et al.  Vascular Inflammation Stratified by C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels: Analysis with 18F-FDG PET , 2011, The Journal of Nuclear Medicine.

[25]  R. Stockley,et al.  Cardiovascular and musculskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency , 2010, Respiratory research.

[26]  Yasmin,et al.  The Impact of Cardiovascular Risk Factors on Aortic Stiffness and Wave Reflections Depends on Age: The Anglo-Cardiff Collaborative Trial (ACCT III) , 2010, Hypertension.

[27]  J. Cockcroft,et al.  Excessive Aortic Inflammation in Chronic Obstructive Pulmonary Disease: An 18F-FDG PET Pilot Study , 2010, The Journal of Nuclear Medicine.

[28]  M. Crilly,et al.  Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose-response relationship independent of established cardiovascular risk factors. , 2009, Rheumatology.

[29]  P. Libby,et al.  Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease , 2009, Circulation.

[30]  V. Fuster,et al.  Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study , 2009, Circulation. Cardiovascular imaging.

[31]  Yasmin,et al.  Aortic Calcification Is Associated With Aortic Stiffness and Isolated Systolic Hypertension in Healthy Individuals , 2009, Hypertension.

[32]  G. Dolivet,et al.  Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  V. Fuster,et al.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. , 2007, Journal of the American College of Cardiology.

[34]  A. Arauz,et al.  Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography Pilot study , 2007, Clinical Neurology and Neurosurgery.

[35]  Chao-Yu Guo,et al.  Cross-Sectional Correlates of Increased Aortic Stiffness in the Community: The Framingham Heart Study , 2007, Circulation.

[36]  Robert A Wise,et al.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee , 2007, Thorax.

[37]  P. Laveneziana,et al.  Physiology and consequences of lung hyperinflation in COPD , 2006, European Respiratory Review.

[38]  Ahmed Tawakol,et al.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. , 2006, Journal of the American College of Cardiology.

[39]  Masatoshi Ishibashi,et al.  Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. , 2006, Journal of the American College of Cardiology.

[40]  B C Stoel,et al.  Validation of computed tomographic lung densitometry for monitoring emphysema in α1-antitrypsin deficiency , 2006, Thorax.

[41]  Martin J Graves,et al.  Identification of Culprit Lesions After Transient Ischemic Attack by Combined 18F Fluorodeoxyglucose Positron-Emission Tomography and High-Resolution Magnetic Resonance Imaging , 2005, Stroke.

[42]  H Tunstall-Pedoe,et al.  Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. , 2005, JAMA.

[43]  I. Wilkinson,et al.  Large artery stiffness and inflammation , 2005, Journal of Human Hypertension.

[44]  Yasmin,et al.  C-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[45]  M. Nieminen,et al.  Progression of Atherosclerosis Is Associated With Variation in the &agr;1-Antitrypsin Gene , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[46]  B. Nordestgaard,et al.  Blood Pressure, Risk of Ischemic Cerebrovascular and Ischemic Heart Disease, and Longevity in &agr;1-Antitrypsin Deficiency: The Copenhagen City Heart Study , 2003, Circulation.

[47]  D. Webb,et al.  Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis , 1998, Journal of hypertension.

[48]  M. Polkey,et al.  Exhaustive treadmill exercise does not reduce twitch transdiaphragmatic pressure in patients with COPD. , 1995, American journal of respiratory and critical care medicine.

[49]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[50]  E. Sharpey-Schafer,et al.  Effects of coughing on intra‐thoracic pressure, arterial pressure and peripheral blood flow , 1953, The Journal of physiology.

[51]  M. Polkey,et al.  Fibrinogen Is Not Associated With Cardiovascular And Muscular Co-Morbidities In Chronic Obstructive Pulmonary Disease: The Erica Study , 2016 .